CAPLIPOINT.NS
Caplin Point Laboratories Ltd
Price:  
2,015.4 
INR
Volume:  
80,385
India | Pharmaceuticals

CAPLIPOINT.NS WACC - Weighted Average Cost of Capital

The WACC of Caplin Point Laboratories Ltd (CAPLIPOINT.NS) is 16.0%.

The Cost of Equity of Caplin Point Laboratories Ltd (CAPLIPOINT.NS) is 16%.
The Cost of Debt of Caplin Point Laboratories Ltd (CAPLIPOINT.NS) is 11.15%.

RangeSelected
Cost of equity14.6% - 17.4%16%
Tax rate19.2% - 19.9%19.55%
Cost of debt7.5% - 14.8%11.15%
WACC14.6% - 17.4%16.0%
WACC

CAPLIPOINT.NS WACC calculation

CategoryLowHigh
Long-term bond rate6.9%7.4%
Equity market risk premium8.3%9.3%
Adjusted beta0.941.03
Additional risk adjustments0.0%0.5%
Cost of equity14.6%17.4%
Tax rate19.2%19.9%
Debt/Equity ratio
00
Cost of debt7.5%14.8%
After-tax WACC14.6%17.4%
Selected WACC16.0%

CAPLIPOINT.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CAPLIPOINT.NS:

cost_of_equity (16.00%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.94) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.